Edgestream Partners, L.P. Haemonetics Corp Transaction History

Edgestream Partners, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$71.24 - $85.35 $1.44 Million - $1.72 Million	20,187 New	20,187 $1.72 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $243,139 - $275,328	2,945 New	2,945 $263,000
Q2 2022 Aug 12, 2022	BUY	$49.27 - $66.08 $559,411 - $750,272	11,354 Added 56.53%	31,440 $2.05 Million
Q1 2022 May 13, 2022	SELL	$43.77 - $63.22 $96,775 - $139,779	-2,211 Reduced 9.92%	20,086 $1.27 Million
Q4 2021 Feb 15, 2022	BUY	$49.55 - $74.59 $1.1 Million - $1.66 Million	22,297 New	22,297 $1.18 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.